Ventyx Biosciences, Inc.
VTYX
$2.52
$0.0753.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.24% | -4.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.16% | -15.91% | |||
| Operating Income | 7.16% | 15.91% | |||
| Income Before Tax | 6.51% | 16.73% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.51% | 16.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.51% | 16.73% | |||
| EBIT | 7.16% | 15.91% | |||
| EBITDA | 7.28% | 15.94% | |||
| EPS Basic | 6.92% | 16.90% | |||
| Normalized Basic EPS | 6.95% | 16.90% | |||
| EPS Diluted | 6.92% | 16.90% | |||
| Normalized Diluted EPS | 6.95% | 16.90% | |||
| Average Basic Shares Outstanding | 0.45% | 0.20% | |||
| Average Diluted Shares Outstanding | 0.45% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||